What Is Hyperbaric Oxygen Therapy

Table of Contents

During hyperbaric oxygen therapy, usually shortened to HBOT, patients breathe oxygen at greater than normal atmospheric pressure inside a sealed chamber. Session length varies by indication, and most conditions treated with HBOT require a course of sessions rather than one.

This therapy was first used in the early 20th century, and became more widely used during the 1940s as increasing numbers of deep-sea divers experienced decompression sickness.

How does hyperbaric oxygen therapy work?

Tissues need oxygen to function, and damaged tissue needs more of it than healthy tissue. At sea level, the blood carries only as much oxygen as haemoglobin can hold. Under pressure, considerably more oxygen dissolves directly into the blood plasma, which raises the amount reaching tissues where the normal blood supply has been damaged or reduced.

In tissue left poorly supplied with blood, that raised oxygen level is used to encourage the growth of new blood vessels and support healing.

What can hyperbaric oxygen therapy be used to treat?

HBOT has a defined set of accepted clinical indications. These include decompression sickness, carbon monoxide poisoning, certain non-healing wounds, necrotising soft tissue infections, and delayed radiation injury to soft tissue and bone.

The Undersea and Hyperbaric Medical Society maintains the list of accepted indications. In the UK, NHS access outside emergency indications is generally through specialist referral or individual funding request rather than routine commissioning.

Outside those accepted indications, evidence for HBOT is limited. Claims about general wellbeing, immunity, energy levels, mood or sleep are not supported by reliable research, and we do not make them.

Hyperbaric oxygen therapy and cancer care

HBOT is not a treatment for cancer. Its relevance to cancer patients is in the longer-term effects of radiotherapy on healthy tissue — osteoradionecrosis and soft tissue radionecrosis, where irradiated tissue is left poorly supplied with blood and slow to heal.

NICE has reviewed HBOT for these indications and acknowledges potential benefit in selected patients, while noting that better quality evidence is still needed.

Hyperbaric oxygen therapy is coming to our London clinic. Read about our HBOT service and register your interest.